Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go:
Extended
investment:
Withheld
Lime Global is a UK-based company dedicated to becoming the most customer-focused provider of health cover. Lime argues that conventional health insurance is too expensive and overly complicated. It intends to make health insurance affordable allowing customers to buy the top-ups they want without consulting advisers or filling long questionnaires. Lime Global claims to provide customers with a cancer cover providing a lump sum and support following diagnosis, access to 'Rapid Diagnostics' to avail private diagnostic tests, and an online platform where customers and employers can book and pay for clinical services. Lime Global aspires to become a contender in the UK private healthcare market set to grow more than £8 billion. The company points out that it has secured 5 star Trustpilot reviews over the last year with zero complaints to date. They intend to use the investment to support their expansion into Small and Medium Enterprises (SMEs), mental health modules and e-pharmacies, scale customer acquisition, and support the next stage of its growth in late 2021 and early 2022.
days to go:
Expired
investment:
£474,838
The Studio enable members to achieve results through sustainable, structured training. The Studio offer a whole range of sessions such as group classes, one-to-one personal training, spinning and yoga.
days to go:
Expired
investment:
£30,564
Marine Power Systems (MPS) is a company that has developed a technology that can harness wind power, wave power or combined wind and wave energy at grid scale. MPS estimates global electricity consumption as a £2 trillion annual market that is growing with a need for harnessing renewable energy sources. The company's mission is to be a world leader in the manufacturing and supply of marine energy extraction hardware. MPS completed a multi-million-pound project to design, manufacture and sea test a 1:4 scale prototype at Falmouth, UK. The company will use the investment to match-fund £17 million of non-dilutive government grant funding that is already secured for a project to design, manufacture and test a full-scale device demonstrator that will prove the technology is ready for commercial scaling.
days to go:
Expired
investment:
£2,151,815
The Idle Man is a fast growing internet retailer with experienced founders. Within the third month of trading The Idle Man was already seeing £100,000 in monthly revenue. This funding round they are aiming to use the money gained from investments to continue their aggressive expansion.
days to go:
Expired
investment:
£1,283,974
Marine Power Systems (MPS) states that it has developed a technology that can harness wind power, wave power or combined wind and wave energy at grid scale. It argues that governments worldwide are looking for alternative sources to meet global energy consumption needs. MPS endeavours to usher in an energy revolution and become a contender in the floating offshore energy market that is set to be worth over $100 billion by 2035. MPS claims to have successfully tested its medium-scaled prototype in the ocean, demonstrating the ease of transportation, deployment, and showcasing the devices ability to generate grid compliant electricity. The company has been awarded a £12.8 million grant by the European Union (EU) to deliver a full scale, grid-connected commercial demonstrator in 2022. It says it will use the investment to conduct its final phase of development and testing before taking its devices to market in Q1 of 2024.
days to go:
Expired
investment:
£4,151,001
Wagonex are a marketplace platform enabling any car manufacturer, supplier or fleet manager to offer cars on a subscription basis. The platform structures and manages flexible solution for fleet management, logistical capability and the audience for distribution.
days to go:
Expired
investment:
£116,412
